Results
1 -
10 of
475
(Click
here to explore results)
The synthesis of Bcr-Abl inhibiting anticancer pharmaceutical agents imatinib, nilotinib and dasatinib . Benjamin J. Deadman, Mark D. Hopkin, Ian R. Baxendale, Steven V. Ley
, Org. Biomol. Chem.
, 2013
, 11
, 1766
Tracking InfraRed signatures of drugs in cancer cells by Fourier Transform microspectroscopy . Giuseppe Bellisola, Marco Della Peruta, Marzia Vezzalini, Elisabetta Moratti, Lisa Vaccari, Giovanni Birarda, Massimo Piccinini, Gianfelice Cinque, Claudio Sorio
, Analyst
, 2010
, 135
, 3077
Differential interactions of imatinib mesylate with the membrane skeletal protein spectrin and hemoglobin . Debashree Das, Ushasi Pramanik, Malay Patra, Mousumi Banerjee, Abhijit Chakrabarti
, RSC Adv.
, 2016
, 6
, 55203
Salidroside enhances the anti-cancerous effect of imatinib on human acute monocytic leukemia via the induction of autophagy-related apoptosis through AMPK activation . Chiyu Ge, Junli Zhang, Feng Feng
, RSC Adv.
, 2019
, 9
, 25022
Simultaneous quantification of imatinib and CGP74588 in human plasma by liquid chromatography-time of flight mass spectrometry (LC-TOF-MS) . S. J. Kumari A. Ubhayasekera, Warunika Aluthgedara, Bo Ek, Jonas Bergquist
, Anal. Methods
, 2016
, 8
, 3046
Protein wrapping: a molecular marker for association, aggregation and drug design . Ariel Fernández, Alejandro Crespo
, Chem. Soc. Rev.
, 2008
, 37
, 2373
Discovery of novel Bcr-Abl inhibitors with diacylated piperazine as the flexible linker . Xiaoyan Pan, Jinyun Dong, Yaling Shi, Ruili Shao, Fen Wei, Jinfeng Wang, Jie Zhang
, Org. Biomol. Chem.
, 2015
, 13
, 7050
Advances in covalent kinase inhibitors . Ayah Abdeldayem, Yasir S. Raouf, Stefan N. Constantinescu, Richard Moriggl, Patrick T. Gunning
, Chem. Soc. Rev.
, 2020
, 49
, 2617
An SPR investigation into the therapeutic drug monitoring of the anticancer drug imatinib with selective aptamers operating in human plasma . Stefano Tartaggia, Anna Meneghello, Ottavia Bellotto, Ariana Soledad Poetto, Martina Zanchetta, Bianca Posocco, David Bunka, Federico Polo, Giuseppe Toffoli
, Analyst
, 2021
, 146
, 1714
Small-world networks of residue interactions in the Abl kinase complexes with cancer drugs: topology of allosteric communication pathways can determine drug resistance effects . A. Tse, G. M. Verkhivker
, Mol. BioSyst.
, 2015
, 11
, 2082